OC 000459 in patients with eosinophilc oesophagitis
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2013
At a glance
- Drugs OC 459 (Primary)
- Indications Eosinophilic oesophagitis
- Focus Biomarker; Therapeutic Use
- 16 Oct 2013 Results presented at the 21st United European Gastroenterology Week.
- 26 May 2012 New trial record
- 22 May 2012 Results presented at Digestive Disease Week 2012.